Search

Your search keyword '"Zecca, Chiara"' showing total 21 results

Search Constraints

Start Over You searched for: Author "Zecca, Chiara" Remove constraint Author: "Zecca, Chiara" Topic 110904 neurology and neuromuscular diseases Remove constraint Topic: 110904 neurology and neuromuscular diseases
21 results on '"Zecca, Chiara"'

Search Results

1. sj-pdf-4-cep-10.1177_03331024231158083 - Supplemental material for Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®

2. sj-pdf-3-cep-10.1177_03331024231158083 - Supplemental material for Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®

3. sj-pdf-4-cep-10.1177_03331024231158083 - Supplemental material for Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®

4. sj-pdf-1-cep-10.1177_03331024231158083 - Supplemental material for Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®

5. sj-pdf-3-cep-10.1177_03331024231158083 - Supplemental material for Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®

6. sj-pdf-2-cep-10.1177_03331024231158083 - Supplemental material for Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®

7. sj-docx-1-msj-10.1177_13524585211020296 – Supplemental material for Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study

8. sj-pdf-2-cep-10.1177_0333102420983292 - Supplemental material for Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database

9. sj-docx-2-msj-10.1177_13524585211020296 – Supplemental material for Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study

10. sj-pdf-2-cep-10.1177_0333102420983292 - Supplemental material for Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database

11. sj-pdf-3-cep-10.1177_0333102420983292 - Supplemental material for Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database

12. sj-doc-2-msj-10.1177_13524585211045545 – Supplemental material for Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis

13. sj-docx-1-msj-10.1177_13524585211020296 – Supplemental material for Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study

14. sj-pdf-3-cep-10.1177_0333102420983292 - Supplemental material for Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database

15. sj-doc-1-msj-10.1177_13524585211045545 – Supplemental material for Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis

16. Supplementary_material – Supplemental material for De-escalating rituximab dose results in stability of clinical, radiological, and serum neurofilament levels in multiple sclerosis

17. Supplementary_table_1 – Supplemental material for Effectiveness of percutaneous posterior tibial nerve stimulation for the management of bowel dysfunction in multiple sclerosis patients

18. MSJ940548_Supplementary_Table_1 – Supplemental material for Longitudinal cortical thinning progression differs across multiple sclerosis phenotypes and is clinically relevant: A multicentre study

19. MSJ865989__STROBE_checklist – Supplemental material for Influence of CNS T2-focal lesions on cervical cord atrophy and disability in multiple sclerosis

20. MSJ865989_supplementary_appendix – Supplemental material for Influence of CNS T2-focal lesions on cervical cord atrophy and disability in multiple sclerosis

21. MSJ872889_supplemental_table – Supplemental material for Treatment of multiple sclerosis with rituximab: A multicentric Italian–Swiss experience

Catalog

Books, media, physical & digital resources